Partial reconstitution of V(D)J rearrangement and lymphocyte development in RAG-deficient mice expressing inducible, tetracycline-regulated RAG transgenes

Molecular Immunology

Volumn 40, Issue 11, 2004, Pages 813-829

  Shockett, Penny E ^a,b   Zhou, Shaoming ^a   Hong, Xiaoming ^a,c   Schatz, David G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHEASTERN LOUISIANA UNIVERSITY   (United States)

^c HOSPITAL OF SAINT RAPHAEL   (United States)

Author keywords

Inducible lymphocyte development; Inducible RAG transgenic mice; Inducible V(D)J recombination; Tetracycline regulated RAG transgenes

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN M; MESSENGER RNA; RAG1 PROTEIN; RAG2 PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE LOCUS; GENE REARRANGEMENT; GENETIC RECOMBINATION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; THYMUS; TRANSGENE; TRANSGENIC MOUSE;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 0347480222     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2003.09.009     Document Type: Article

References (47)

1. Baker A.J., Redfern C.H., Harwood M.D., Simpson P.C., Conklin B. Abnormal contraction caused by expression of G(i)-coupled receptor in transgenic model of dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H1653-H1659.
2. Baireto V., Marques R., Demengeot J. Early death and severe lymphopenia caused by ubiquitous expression of the Rag1 and Rag2 genes in mice. Eur. J. Immunol. 31:2001;3763-3772.
3. Bassing C.H., Swat W., Alt F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 109(Suppl.):2002;S45-S55.
4. Blau H.M., Rossi F.M. Tet B or not tet B: advances in tetracycline-inducible gene expression. Proc. Natl. Acad. Sci. U.S.A. 96:1999;797-799.
5. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1999;1639-1648.
6. Chen J., Kelz M.B., Zeng G., Sakai N., Steffen C., Shockett P.E., Picciotto M.R., Duman R.S., Nestler E.J. Transgenic animals with inducible, targeted gene expression in brain. Mol. Pharmacol. 54:1998;495-503.
7. Efrat S., Fusco-DeMane D., Lemberg H., al Emran O., Wang X. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. Sci. U.S.A. 92:1995;3576-3580.
8. Ewald D., Li M., Efrat S., Auer G., Wall R.J., Furth P.A., Hennighausen L. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science. 273:1996;1384-1386.
9. Freitas A.A., Agnes F. Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J. Exp. Med. 189:1999;319-329.
10. Fugmann S.D. RAG1 and RAG2 in V(D)J recombination and transposition. Immunol. Res. 23:2001;23-39.
11. Fugmann S.D., Lee A.I., Shockett P.E., Villey I.J., Schatz D.G. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18:2000;495-527.
12. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Ann. Rev. Biochem. 71:2002;101-132.
13. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89:1992;5547-5551.
14. Grawunder U., Leu T.M.J., Schatz D.G., Werner A., Rolink A.G., Melchers F., Winkler T.H. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity. 3:1995;601-608.
15. Green E.A., Wong F.S., Eshima K., Mora C., Flavell R.A. Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD 154-independent antigen presentation to CD8(+) T cells. J. Exp. Med. 191:2000;225-238.
16. Kelz M.B., Chen J., Carlezon W.A. Jr., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., Nestler E.J. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature. 401:1999;272-276.
17. Kelz M.B., Kuszak J.R., Yang Y., Ma W., Steffen C., Al-Ghoul K., Zhang Y.J., Chen J., Nestler E.J., Spector A. DeltaFosB-induced cataract. Invest. Ophthalmol. Vis. Sci. 41:2000;3523-3538.
18. Lee J., Desiderio S. Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity. 11:1999;771-781.
19. Lewis S., Rosenberg N., Alt F., Baltimore D. Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell. 30:1982;807-816.
20. Lin W.-C., Desiderio S. Cell cycle regulation of V(D)J recombination activating protein RAG-2. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2733-2737.
21. Livàk F., Schatz D.G. T-cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells. Mol. Cell. Biol. 16:1996;609-618.
22. Livàk F., Petrie H.T., Crispe I.N., Schatz D.G. In-frame TCR δ gene rearrangements play a critical role in the αβ/ γδ T cell lineage decision. Immunity. 2:1995;617-627.
23. Livàk F., Wilson A., MacDonald H.R., Schatz D.G. αβ lineage committed thymocytes can be rescued by the γδ TCR in the absence of TCR-β chain. Eur. J. Immunol. 27:1997;2948-2958.
24. Livak F., Tourigny M., Schatz D.G., Petrie H.T. Characterization of TCR gene rearrangements during adult murine T cell development. J. Immunol. 162:1999;2575-2580.
25. Malleret G., Haditsch U., Genoux D., Jones M.W., Bliss T.V., Vanhoose A.M., Weitlauf C., Kandel E.R., Winder D.G., Mansuy I.M. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell. 104:2001;675-686.
26. Mayford M., Bach M.E., Huang Y.Y., Wang L., Hawkins R.D., Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science. 274:1996;1678-1683.
27. Petrie H.T., Livàk F., Schatz D.G., Strasser A., Crispe I.N., Shortman K. Multiple rearrangements in T-Cell receptor α-chain genes maximize the production of useful thymocytes. J. Exp. Med. 178:1993;615-622.
28. Ramsden D.A., Gellert M. Formation and resolution of double-strand break intermediates in V(D)J rearrangement. Genes Dev. 9:1995;2409-2420.
29. Ray P., Tang W., Wang P., Homer R., Kuhn C. III, Flavell R.A., Elias J.A. Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and development-independent phenotypes. J. Clin. Invest. 100:1997;2501-2511.
30. Sabatakos G., Sims N.A., Chen J., Aoki K., Kelz M.B., Amling M., Bouali Y., Mukhopadhyay K., Ford K., Nestler E J., Baron R. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6:2000;985-990.
31. Sadofsky M.J., Hesse J.E., van Gent D.C., Gellert M. RAG-1 mutations that affect the target specificity of V(D)J recombination - a possible direct role of RAG-1 in site recognition. Genes Dev. 9:1995;2193-2199.
32. Sant'Angelo D.B., Waterbury G., Preston-Hurlburt P., Yoon S.T., Medzhitov R.S.C.H., Janeway C.A. Jr. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity. 4:1996;367-376.
33. Schlissel M.S., Baltimore D. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell. 58:1989;1001-1007.
34. Schlissel M.S., Corcoran L.M., Baltimore D. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobin gene rearrangement and transcription. J. Exp. Med. 173:1991;711-720.
35. Shinkai Y., Rathbun G., Kong-Peng L., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M., Alt F.W. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:1992;855-867.
36. Shinkai Y., Koyasu S., Nakayama K.-I., Murphy K.M., Loh D.Y., Reinherz E.L., Alt F.W. Restoration of T-cell development in RAG-2 deficient mice by functional TCR transgenes. Science. 259:1993;822-825.
37. Shockett, P.E., 1997. Inducible expression in mammalian cells using a tetracycline-regulated system. Curr. Protocols Mol. Biol., Unit 16.2.1.
38. Shocken P.E., Schatz D.G. Diverse strategies for tetracycline-regulated inducible gene expression. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5173-5176.
39. Shockett P.E., Schatz D.G. Switching on gene expression. Nat. Biotechnol. 15:1997;221-223.
40. Shockett P., Difilippantonio M., Hellman N., Schatz D.G. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 92:1995;6522-6526.
41. Spanopoulou E., Roman C.A.J., Corcoran L.M., Schlissel M.S., Silver D.P., Nemazee D., Nussenzweig M.C., Shinton S.A., Hardy R.R., Baltimore D. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev. 8:1994;1030-1042.
42. Wayne J., Suh H.Y., Misulovin Z., Sokol K.A., Inaba K., Nussenzweig M.C. A regulatory role for recombinase activating genes, RAG-1 and RAG-2, in T cell development. Immunity. 1:1994a;95-107.
43. Wayne J., Suh H.Y., Sokol K.A., Petrie H.T., Witmerpack M., Edelhoff S., Disteche C.M., Nussenzweig M.C. TCR selection and allelic exclusion in RAG transgenic mice that exhibit abnormal T cell localization in lymph nodes and lymphatics. J. Immunol. 153:1994b;5491-5502.
44. Wilson A., Held W., Macdonald H.R. Two waves of recombinase gene expression in developing thymocytes. J. Exp. Med. 179:1994;1355-1360.
45. Yamamoto A., Lucas J.J., Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell. 101:2000;57-66.
46. Yannoutsos N., Wilson P., Wong Y., Chen H.T., Nussenzweig A., Petrie H., Nusseniweig M.C. The role of recombination activating gene (RAG) reinduction in thymocyte development in vivo. J. Exp. Med. 194:2001;471-480.
47. Young F., Ardman B., Shinkai Y., Lansford R., Blackwell T.K., Mendelsohn M., Rolink A., Melchers F., Alt F.W. Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation. Genes Dev. 8:1994;1043-1057.